Polaris Market Research recently published [115+ Pages] research report on “Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product (Cardiac Resynchronization Therapy, Counter Pulsation Devices, ICD, Pacemakers, Ventricular Assist Devices, Others); By End-Use; By Region; Segment Forecast, 2022 – 2030” in its research database.
According to the [115+ Pages] research report, the global congestive heart failure market size was valued at USD 11.54 billion in 2021 and is expected to reach USD 18.48 Billion by 2030, growing at a CAGR of 5.4% during the forecast period.
What is Congestive Heart Failure? How Big is the Size & Share of Congestive Heart Failure Market?
Congestive heart failure takes place when the heart muscle does not pump blood as well as it should. When this happens, blood usually retreats, causing fluid to build up in the lungs giving rise to breathing shortness. The rapidly rising demand for the congestive heart failure market can be attributed to people becoming more aware of regular exercise, being active, walking every day, and stopping the use of tobacco products.
The market is witnessing growth due to a strong product pipeline, an escalating geriatric population, and growing R&D for drug development. Another prominent factor easing the growth is the rising burden of diseases such as hypertension, diabetes, obesity, chronic pulmonary disease, and renal disease as they are contemplated CHF-linked notable co-morbidities.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/global-congestive-heart-failure-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
What Does the Report Include?
- Quantitative analysis of market segments, prevalent trends, estimations, and dynamics of the treatment devices to recognize market opportunities
- Porter’s five forces analysis underscores the buyer and supplier potency to facilitate profit-oriented business decisions
- Prominent countries in each region are mapped as per the revenue contribution of the global market
- Market player positioning eases benchmarking and offers a clear comprehension of the prevailing position of the market players.
Some of the Top Market Players Are:
- Berlin Heart
- Abbot Laboratories
- Aspect Imaging Ltd
- General Electric
- Koninklijke Philips
- Neusoft Corporation
- OMRON Corporation
- Jarvik Heart
- Jude Medical
- Lepu Medical
- Osypka Medical GmbH
- Boston Scientific Corporation
To Know Additional Information on Market Players, Download Sample PDF Brochure
Growth Driving Factors
- Medicines to lessen cardiovascular death and hospitalization to push the market
Presently pharmacological alternatives for the disease are taking calculated steps for a better treatment viewpoint through product approvals and contemporary product instigations. For instance, in February 2022, the FDA sanctioned Boehringer Ingelheim’s Jardiance to lessen cardiovascular death and hospitalization in adults. Therefore, new approvals and launches are the reason for expanding the congestive heart failure market size.
Additionally, the boom in R&D activities and the appearance of many drugs under the clinical pipeline generate lucrative opportunities and vicious competition among companies. For instance, in February 2022, the FDA obtained NDA for Cytokinetics’ drug Omecamtiv Mecarbil, a judicious cardiac myosin activator productive in enhancing contractility linked with heart failure. CHF clinical trial drugs include Furoscix infusor, CardiAMP cell therapy, Revascor (Rexlemestrocel-L), semaglutide, tirzepatide, cimlanod, and others. Therefore, approval and successive launch of such drugs are accountable for the surge in the soaring congestive heart failure market sales.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/2891
Boston Scientific obtained the urbane transseptal access solutions company Baylis Medical Company in February 2022. Boston Scientific appealed to expand its position in the cardiology market by obtaining the Baylis platform into its portfolio of offerings.
- The evolving pharmaceutical and medical device R&D to boost the market
Based on the product, the pacemakers segment had the highest revenue share in the congestive heart failure treatment technologies market. The segment is growing due to a growth in pacemaker use and pharmaceutical and medical device R&D. The congestive heart failure market demand is on the rise as the pacemakers are well-liked by both the surgeons and the patients because it effortlessly sustains the cardiac rhythm. For instance, Medtronic introduced the most compact pacemaker in the world to cure heart block in June 2021.
- The increasing concentration on skilled professionals in hospitals to propel the market
Based on end use, the hospital segment is anticipated to hold a significant revenue share. The increasing number of patients and sizeable focus on skilled professionals in hospital settings have caused the growth of this segment. The congestive heart failure market trends include expanding hospital population and encouraging sector expansion during the projection period.
Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/global-congestive-heart-failure-market/request-for-discount-pricing
Congestive Heart Failure Market: Report Scope
|Market Outlook for 2030||USD 18.48 Billion|
|Market Size 2022 Value||USD 12.09 Billion|
|Expected CAGR Growth||5.4% from 2022 – 2030|
|Forecast Year||2022 – 2030|
|Top Market Players||ABIOMED, LivaNova, Jarvik Heart Inc., Berlin Heart, Abbot Laboratories, Aspect Imaging Ltd, CANON MEDICAL SYSTEMS CORPORATION, Siemens, General Electric, Hitachi, Koninklijke Philips N.V., Neusoft Corporation, ESAOTE SPA, Medtronic, OMRON Corporation, Dexcom, Masimo, Jarvik Heart, Biotronik, Teleflex, St. Jude Medical, Lepu Medical, Jarvik Heart, Osypka Medical GmbH, Medtronic, and Boston Scientific Corporation.|
|Segments Covered||By Product, By End-Users, By Region|
|Customization Options||Customized purchase options are available to meet your research needs. Explore customized purchase options|
- A robust clinical pipeline would drive the market in the North American region
North America held the largest congestive heart failure market share as there is an establishment of leading manufacturers in the US and the growing pervasiveness of cardiac disorders in both the US and Canada. Additionally, it is estimated that a robust clinical pipeline, complimentary remuneration rules for therapeutic items, and pronounced acceptance of these devices would all contribute to an increase in revenue.
Browse the Detail Report “Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product (Cardiac Resynchronization Therapy, Counter Pulsation Devices, ICD, Pacemakers, Ventricular Assist Devices, Others); By End-Use; By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/global-congestive-heart-failure-market
For Additional Information OR Media Enquiry, Please Mail Us At: email@example.com
Frequently Asked Questions
- What is the future market value for the CHF market?
- What is the growth rate of the CHF market?
- Who are the major players operating in the market?
- What are the major countries covered in the market?
- Which segment accounted for the largest market share?
By Product Outlook
- Ventricular Assist Devices
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy
- Counter Pulsation Devices
By End Use Outlook
- Hospitals & Clinic
- Specialized Cardiovascular Disease Treatment Centres
- Ambulatory Surgery Centres
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
30 Wall Street
New York City, NY 10005,
Phone: +1-929 297-9727